SNM1A is crucial for efficient repair of complex DNA breaks in human cells




Swift, Lonnie P.; Lagerholm, B. Christoffer; Henderson, Lucy R.; Ratnaweera, Malitha; Baddock, Hannah T.; Sengerova, Blank; Lee, Sook; Cruz-Migoni, Abimael; Waithe, Dominic; Renz, Christian; Ulrich, Helle D.; Newman, Joseph A.; Schofield, Christopher J.; McHugh, Peter J.

PublisherSpringer Nature

2024

Nature Communications

Nature communications

Nat Commun

5392

15

1

2041-1723

DOIhttps://doi.org/10.1038/s41467-024-49583-5

https://research.utu.fi/converis/portal/detail/Publication/457028912



DNA double-strand breaks (DSBs), such as those produced by radiation and radiomimetics, are amongst the most toxic forms of cellular damage, in part because they involve extensive oxidative modifications at the break termini. Prior to completion of DSB repair, the chemically modified termini must be removed. Various DNA processing enzymes have been implicated in the processing of these dirty ends, but molecular knowledge of this process is limited. Here, we demonstrate a role for the metallo-β-lactamase fold 5'-3' exonuclease SNM1A in this vital process. Cells disrupted for SNM1A manifest increased sensitivity to radiation and radiomimetic agents and show defects in DSB damage repair. SNM1A is recruited and is retained at the sites of DSB damage via the concerted action of its three highly conserved PBZ, PIP box and UBZ interaction domains, which mediate interactions with poly-ADP-ribose chains, PCNA and the ubiquitinated form of PCNA, respectively. SNM1A can resect DNA containing oxidative lesions induced by radiation damage at break termini. The combined results reveal a crucial role for SNM1A to digest chemically modified DNA during the repair of DSBs and imply that the catalytic domain of SNM1A is an attractive target for potentiation of radiotherapy.


This work was supported by a Cancer Research UK Programme Award (CRUK/ A24759) to P.J.M. and C.J.S. M.R. receives an MRC Graduate Studentship, L.R.H. has received a Wellcome Trust Studentship and S.L. was supported by a National Science Scholarship from the Singaporean Agency for Science, Technology, and Research (A*STAR). We thank Opher Gileadi for purified APLF, Paul Modrich for EXO1 constructs, Philip Hublitz for help with CRISPR guide design, and Andrew Blackford for sharing XRCC4 disrupted cells. George-Lucian Moldovan kindly provided 293 T PCNAK164R cells.


Last updated on 2025-27-01 at 19:56